| 1 |
Zhu T, Liu H, Gao S, Chen S, Jiang N, Xie W. Brain Network Homeostasis and Plasticity of Salidroside for Achieving Neuroprotection and Treating Psychiatric Sequelae Stemming from Stress.. [DOI: 10.21203/rs.3.rs-2408379/v1] [Reference Citation Analysis]
|
| 2 |
Zhang H, Lv P, Jiang J, Liu Y, Yan R, Shu S, Hu B, Xiao H, Cai K, Yuan S, Li Y. Advances in developing ACE2 derivatives against SARS-CoV-2. Lancet Microbe 2023:S2666-5247(23)00011-3. [PMID: 36934742 DOI: 10.1016/S2666-5247(23)00011-3] [Reference Citation Analysis]
|
| 3 |
Wang Y, Zhou X, Wei S, Wang G, Xi J. Current status and future challenges in extraction, purification and identification of Cepharanthine (a potential drug against COVID-19). Sep Purif Technol 2023;309:123038. [PMID: 36593875 DOI: 10.1016/j.seppur.2022.123038] [Reference Citation Analysis]
|
| 4 |
Cetinkaya A, Kaya SI, Ozkan SA. A Comprehensive Overview of Sensors Applications for the Diagnosis of SARS-CoV-2 and of Drugs Used in its Treatment. Crit Rev Anal Chem 2023;:1-21. [PMID: 36877165 DOI: 10.1080/10408347.2023.2186693] [Reference Citation Analysis]
|
| 5 |
Kim JW, Heo K, Kim HJ, Yoo Y, Cho HS, Jang HJ, Lee HY, Ko IY, Woo JR, Cho YB, Lee JH, Yang HR, Shin HG, Choi HL, Hwang K, Kim S, Kim H, Chun K, Lee S. Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants. Antiviral Res 2023;212:105576. [PMID: 36870394 DOI: 10.1016/j.antiviral.2023.105576] [Reference Citation Analysis]
|
| 6 |
Castellan M, Zamperin G, Franzoni G, Foiani G, Zorzan M, Drzewnioková P, Mancin M, Brian I, Bortolami A, Pagliari M, Oggiano A, Vascellari M, Panzarin V, Crovella S, Monne I, Terregino C, De Benedictis P, Leopardi S. Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes. Viruses 2023;15. [PMID: 36851642 DOI: 10.3390/v15020428] [Reference Citation Analysis]
|
| 7 |
Meng JR, Liu J, Fu L, Shu T, Yang L, Zhang X, Jiang ZH, Bai LP. Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD. Viruses 2023;15:160. [PMID: 36680200 DOI: 10.3390/v15010160] [Reference Citation Analysis]
|
| 8 |
Philip AM, Ahmed WS, Biswas KH. Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2. Comput Struct Biotechnol J 2023;21:1966-77. [PMID: 36936816 DOI: 10.1016/j.csbj.2023.02.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ji X, Meng X, Zhu X, He Q, Cui Y. Research and development of Chinese anti-COVID-19 drugs. Acta Pharm Sin B 2022;12:4271-86. [PMID: 36119967 DOI: 10.1016/j.apsb.2022.09.002] [Reference Citation Analysis]
|
| 10 |
Eltaib L, Alzain AA. Targeting the omicron variant of SARS-CoV-2 with phytochemicals from Saudi medicinal plants: molecular docking combined with molecular dynamics investigations. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2146203] [Reference Citation Analysis]
|
| 11 |
Zerrouki A, Abrigach F, Taleb M, Kadiri SE. Towards potent Covid-19 spike protein inhibitors and catecholase activity agents: Synthesis, ADME-Tox analysis and molecular docking of new 1,2,4- triazole-based molecules.. [DOI: 10.21203/rs.3.rs-2238807/v1] [Reference Citation Analysis]
|
| 12 |
Masaret GS, Farghaly TA, Al-hussain SA, Zaki MEA, Alsaedi AMR, Muhammad ZA. Site-Selectivity of the Reaction of 3-Amino-4-Cyano-5-Phenyl-1 H -Pyrrole-2-Carboxylic Acid Amide with α-Halocarbonyl Compounds. Antimicrobial Activity and Docking Study for COVID-19 of the Products. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2130371] [Reference Citation Analysis]
|
| 13 |
Alexander Muacevic, John R Adler. Breastfeeding Practices During COVID-19: A Narrative Article. Cureus;14:e30588. [PMID: 36420243 DOI: 10.7759/cureus.30588] [Reference Citation Analysis]
|
| 14 |
Ebata S, Yoshizaki-Ogawa A, Sato S, Yoshizaki A. New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics. J Clin Med 2022;11:4631. [PMID: 35956246 DOI: 10.3390/jcm11154631] [Reference Citation Analysis]
|
| 15 |
Shah MR, Fatima S, Khan SN, Ullah S, Himani G, Wan K, Lin T, Lau JYN, Liu Q, Lam DSC. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial. Front Med 2022;9. [DOI: 10.3389/fmed.2022.928468] [Reference Citation Analysis]
|
| 16 |
Pang Z, Hu R, Tian L, Lou F, Chen Y, Wang S, He S, Zhu S, An X, Song L, Liu F, Tong Y, Fan H. Overview of Breastfeeding Under COVID-19 Pandemic. Front Immunol 2022;13:896068. [PMID: 35711421 DOI: 10.3389/fimmu.2022.896068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Jodłowski PJ, Dymek K, Kurowski G, Jaśkowska J, Bury W, Pander M, Wnorowska S, Targowska-Duda K, Piskorz W, Wnorowski A, Boguszewska-Czubara A. Zirconium-Based Metal-Organic Frameworks as Acriflavine Cargos in the Battle against Coronaviruses─A Theoretical and Experimental Approach. ACS Appl Mater Interfaces 2022. [PMID: 35700479 DOI: 10.1021/acsami.2c06420] [Reference Citation Analysis]
|
| 18 |
Shah MR, Fatima S, Khan SN, Shafiullah, Himani G, Wan K, Lin T, Lau JY, Liu Q, Lam DS. Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial.. [DOI: 10.1101/2022.05.16.22275074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
Sevak G, Singh Chauhan Y, Parihar N, Singh Rathore M. Review of Novel Corona Virus Disease (Covid-19) in India. RJPPD 2022. [DOI: 10.52711/2321-5836.2022.00018] [Reference Citation Analysis]
|
| 20 |
Huang Y, Ling Q, Manyande A, Wu D, Xiang B. Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review. Front Neurosci 2022;16:855868. [DOI: 10.3389/fnins.2022.855868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
